Yang Mengting, Li Xiaoxiao, Lin Chen, Liu Mingjing, Chen Yezi, Zhao Yun, Liu Chaoqi
Hubei Provincial Key Laboratory of Tumor Microenvironment and Immunotherapy, School of Medicine, China Three Gorges University, Yichang 443002, Hubei, China.
School of Medicine, China Three Gorges University, Yichang 443002, Hubei, China.
Sheng Wu Gong Cheng Xue Bao. 2021 Apr 25;37(4):1368-1375. doi: 10.13345/j.cjb.200569.
Diphtheria toxin is an ADP-ribosyltransferase toxic to human cells. Mutation of the active site in its catalytic domain eliminates the toxicity, but retains its immunogenicity. A non-toxic mutant of diphtheria toxin known as CRM197 protein has become an ideal carrier protein for conjugate vaccines. CRM197 can further improve its immunogenicity by cross-linking with other antigens, so it has good potential to find broad applications. Unfortunately, inclusion bodies are easily formed during the expression of recombinant CRM197 protein in Escherichia coli, which greatly reduces its yield. In order to address this problem, pG-KJE8 vector carrying molecular chaperones and plasmid pET28a-CRM197, were co-expressed in Escherichia coli. The results showed that the recombinant CRM197 protein was successfully expressed and appeared largely in inclusion bodies. The molecular chaperones DnaK, DnaJ, GrpE, GroES and GroEL5 expressed can facilitate correct and rapid folding of CRM197. Furthermore, it can also improve the recovery rate of soluble CRM197 protein. The soluble expression of CRM197 was maximized upon addition of 1.0 mmol/L IPTG, 0.5 mg L-arabinose, 5.0 ng/mL tetracycline and induction at 20oC for 16 h. The soluble CRM197 protein shows good immunoreactivity, demonstrating the molecular chaperones expressed from pG-KJE8 facilitated the soluble expression of CRM197 protein in E. coli.
白喉毒素是一种对人类细胞有毒的ADP核糖基转移酶。其催化结构域中活性位点的突变消除了毒性,但保留了免疫原性。一种名为CRM197蛋白的白喉毒素无毒突变体已成为结合疫苗的理想载体蛋白。CRM197可通过与其他抗原交联进一步提高其免疫原性,因此具有广泛应用的良好潜力。不幸的是,在大肠杆菌中表达重组CRM197蛋白时容易形成包涵体,这大大降低了其产量。为了解决这个问题,携带分子伴侣的pG-KJE8载体和质粒pET28a-CRM197在大肠杆菌中共表达。结果表明,重组CRM197蛋白成功表达,且大量出现在包涵体中。表达的分子伴侣DnaK、DnaJ、GrpE、GroES和GroEL5可促进CRM197的正确快速折叠。此外,它还可以提高可溶性CRM197蛋白的回收率。在添加1.0 mmol/L异丙基硫代半乳糖苷(IPTG)、0.5 mg L-阿拉伯糖、5.0 ng/mL四环素并在20℃诱导16小时后,CRM197的可溶性表达达到最大化。可溶性CRM197蛋白显示出良好免疫反应性,表明从pG-KJE8表达的分子伴侣促进了CRM197蛋白在大肠杆菌中的可溶性表达。